DK0686159T3 - Farnesyl-proteintransferaseinhibitorer som anticancermidler - Google Patents

Farnesyl-proteintransferaseinhibitorer som anticancermidler

Info

Publication number
DK0686159T3
DK0686159T3 DK94909497.3T DK94909497T DK0686159T3 DK 0686159 T3 DK0686159 T3 DK 0686159T3 DK 94909497 T DK94909497 T DK 94909497T DK 0686159 T3 DK0686159 T3 DK 0686159T3
Authority
DK
Denmark
Prior art keywords
anticancer agents
protein transferase
transferase inhibitors
farnesyl protein
alkyl
Prior art date
Application number
DK94909497.3T
Other languages
English (en)
Inventor
David M Stemerick
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0686159T3 publication Critical patent/DK0686159T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015Esters of acyclic unsaturated acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3821Acyclic saturated acids which can have further substituents on alkyl substituted by B, Si, P or a metal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • C07F9/4012Esters of acyclic acids which can have further substituents on alkyl substituted by B, Si, P or a metal

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94909497.3T 1993-02-23 1994-01-24 Farnesyl-proteintransferaseinhibitorer som anticancermidler DK0686159T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2141193A 1993-02-23 1993-02-23

Publications (1)

Publication Number Publication Date
DK0686159T3 true DK0686159T3 (da) 1998-01-26

Family

ID=21804071

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94909497.3T DK0686159T3 (da) 1993-02-23 1994-01-24 Farnesyl-proteintransferaseinhibitorer som anticancermidler

Country Status (19)

Country Link
US (1) US5463181A (da)
EP (1) EP0686159B1 (da)
JP (1) JPH08509470A (da)
KR (1) KR100305128B1 (da)
CN (1) CN1045207C (da)
AT (1) ATE159023T1 (da)
AU (1) AU684071B2 (da)
CA (1) CA2154871C (da)
DE (1) DE69406110T2 (da)
DK (1) DK0686159T3 (da)
ES (1) ES2110738T3 (da)
FI (1) FI111369B (da)
GR (1) GR3025499T3 (da)
HU (1) HUT72647A (da)
IL (1) IL108694A0 (da)
NO (1) NO306618B1 (da)
NZ (1) NZ262585A (da)
TW (1) TW265345B (da)
ZA (1) ZA941099B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
FR2833266B1 (fr) * 2001-12-11 2004-10-22 Mayoly Spindler Lab Nouveaux derives phosphonates, leur procede de preparation, leur utilisation comme modulateurs de l'activite des lymphocytes tgamma9 delta2
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57142993A (en) * 1981-02-28 1982-09-03 Sagami Chem Res Center 2-hydroxyphosphonic diester
DE3313070A1 (de) * 1983-04-12 1984-10-18 Bayer Ag, 5090 Leverkusen Chlorierte phosphorylmethylcarbonyl-derivate, verfahren zu ihrer herstellung und ihre verwendung in pflanzenschutmitteln
DE3425701A1 (de) * 1984-07-12 1986-01-16 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von chlorierten phosphorylmethylcarbonyl-derivaten und neue zwischenprodukte zu ihrer herstellung
US4924024A (en) * 1988-01-11 1990-05-08 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors, new intermediates and method
US5177239A (en) * 1989-07-18 1993-01-05 E. R. Squibb & Sons, Inc. Method for preparing a phosphonic acid ester
US5298655A (en) * 1991-09-27 1994-03-29 Merck & Co., Inc. Farnesyl pyrophosphate analogs

Also Published As

Publication number Publication date
AU6232494A (en) 1994-09-14
ATE159023T1 (de) 1997-10-15
GR3025499T3 (en) 1998-02-27
AU684071B2 (en) 1997-12-04
FI953934L (fi) 1995-08-22
CA2154871A1 (en) 1994-09-01
TW265345B (da) 1995-12-11
NO953292D0 (no) 1995-08-22
HUT72647A (en) 1996-05-28
JPH08509470A (ja) 1996-10-08
CN1045207C (zh) 1999-09-22
EP0686159B1 (en) 1997-10-08
EP0686159A1 (en) 1995-12-13
NO306618B1 (no) 1999-11-29
NO953292L (no) 1995-08-22
NZ262585A (en) 1997-12-19
KR100305128B1 (ko) 2001-11-22
FI953934A0 (fi) 1995-08-22
CN1118166A (zh) 1996-03-06
FI111369B (fi) 2003-07-15
DE69406110T2 (de) 1998-05-14
DE69406110D1 (de) 1997-11-13
ES2110738T3 (es) 1998-02-16
HU9502455D0 (en) 1995-10-30
US5463181A (en) 1995-10-31
CA2154871C (en) 1998-04-07
IL108694A0 (en) 1994-05-30
ZA941099B (en) 1994-08-30

Similar Documents

Publication Publication Date Title
DE69533948D1 (de) Kalzium-Rezeptor aktive Verbindungen
DK0720599T3 (da) Som hypocholesterolæmiske midler anvendelige hydroxysubstituerede azetidinoner
AU3317495A (en) Aroyl-piperidine derivatives
NO953292L (no) Farnesyl:proteintransferaseinhibitorer som anticancermidler
NO942197D0 (no) Fremgangsmåte og anordning for direkte bestemmelse av LD-lipoprotein
DK0769296T3 (da) Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer
CO4290351A1 (es) Proceso
PT861837E (pt) Novos compostos de 2-amino-indano processo para a sua preparacao e as composicoes farmaceuticas que os contem
ATE139698T1 (de) Mittel zur behandlung chronischer ermüdungserscheinungen
FI915044A0 (fi) Korrosionsinhibitorer foer anvaendning i belaeggningskompositioner som innehaoller synergistiska kombinationer av kalciumborater och aminokarboxylater.
ES8604532A1 (es) Procedimiento de preparacion de nuevos derivados as-triazinos condensados
ES2116528T3 (es) Nuevo compuesto, la leustroducsina h, su preparacion y su utilizacion terapeutica.
CS746285A2 (en) Method of as-triazine's new fussed derivatives preparation
HUP9701382A2 (hu) Új 7,8-dihidro-8-metil-9H-1,3-dioxolo-[4,5-h][2,3]-benzodiazepin-származékok, ilyen hatóanyagot tartalmazó gyógyászati készítmény, és eljárás a hatóanyag előállítására
HUP9701383A2 (hu) Új 8-metil-7H-1,3-dioxolo[4,5h][2,3]-benzodiazepin-származékok, ilyen hatóanyagot tartalmazó gyógyászati készítmény, és eljárás a hatóanyag előállítására